Steris | STE - Betriebsergebnis

Aktienkurs
221.80
Täglich Wechseln
-1.72 -0.77%
Monatlich
-0.71%
Jährlich
-1.42%
Q2 Prognose
217.05




Betriebsergebnis Veränderung Datum
3M USD 1.55B 337M 2026-03
Accuray USD 4.71M 6.86M 2024-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Ecolab USD 786.6M 200K 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Fortive USD 225.5M 65.9M 2025-12
Getinge SEK 1.08B 900M 2024-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Masimo USD 83.9M 300K 2025-12
Olympus JPY 28B 5.56B 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
Owens Minor USD 814K 28.08M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12